Clinical Trial Update: Effect on Metabolic Parameters of Abilify in SPR

View source ↗

Summary

This clinical trial update evaluates the effects of Abilify (aripiprazole) on metabolic parameters in patients with schizophrenia and metabolic syndrome. The sp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome
• Schizophrenia

Drugs mentioned

• Abilify (aripiprazole)

Snippet

Sponsor: Seoul National Hospital | Conditions: Schizophrenia, Metabolic Syndrome | Status: UNKNOWN